Formulary Tier Placement for Commonly Prescribed Branded Drugs: Benchmarking and Creation of a Preferred Placement Index
Effects of Benefit Design Change Across 5 Disease States
Consumer Response to Dual Incentives Under Multitiered Prescription Drug Formularies
Incentive Formularies and Changes in Prescription Drug Spending
Relationship Between Generic and Preferred-brand Prescription Copayment Differentials and Generic Fill Rate
Effect of a Medication Copayment Increase in Veterans With Schizophrenia
Effect of Copayments on Drug Use in the Presence of Annual Payment Limits
"Fiscally Responsible, Clinically Sensitive" Cost Sharing: Contain Costs While Preserving Quality
